Dianthus Therapeutics | MGTA - Interest Expense On Debt



Dianthus Therapeutics reported 4.44M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.35M 230K Jun/2024
Celltrion KRW 17.04B 1.34B Mar/2025
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Moderna USD 1000K 0 Jun/2025
Neuren Pharmaceuticals 0 0 Jun/2024
Organon & Co USD 131M 7M Jun/2025
Qiagen NV USD 7.6M 311K Jun/2025
Revvity USD 22.94M 27K Jun/2025
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tectonic Therapeutic USD 17K 5K Jun/2025
Tilray USD 7.77M 2.08M Nov/2024
Viatris USD 116.6M 1.1M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025